title: What is drug-induced long QT and what is a potential clinical consequence?
authors.affiliation: Stanford University Medical Center, Palo Alto, CA 99305, USA. atsiperfal@stanfordmed.org
authors.forename: Angela
authors.initials: A
authors.lastname: Tsiperfal
authors.forename: Michelle
authors.initials: M
authors.lastname: Gould
authors.forename: Christine
authors.initials: C
authors.lastname: Thompson
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000378:metabolism; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000378:metabolism; D016903:Drug Monitoring / Q000451:nursing; D004562:Electrocardiography / Q000451:nursing; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced / Q000175:diagnosis; D008297:Male; D008657:Metabolic Clearance Rate; D009730:Nursing Assessment / Q000379:methods; D010627:Phenethylamines / Q000009:adverse effects* / Q000378:metabolism; D013449:Sulfonamides / Q000009:adverse effects* / Q000378:metabolism; D013686:Telemetry; D016171:Torsades de Pointes / Q000139:chemically induced / Q000175:diagnosis
chemical_list: D000889:Anti-Arrhythmia Agents; D010627:Phenethylamines; D013449:Sulfonamides; C063533:dofetilide